22nd May 2023
AHFS Drug Information
This update contains 4 new monographs and 25 revised monographs….
AHFS Drug Information
Evaluative evidence-based guidance for safe and effective drug therapy
Published by the American Society of Health-System Pharmacists (ASHP), AHFS Drug Information is a dependable, comprehensive, and objective database for drug products approved by the FDA.
The American Hospital Formulary Service (AHFS) drug information database is maintained and updated continuously throughout the year.
The inclusion of evidence-based data on licensed and unlicensed drug use makes this a valuable reference for health professionals seeking to provide their patients with safe and effective therapy.
- 96k+
- Uniquely cited references
- 62k+
- Supporting evidence sources
- 500+
- Peer reviews
- 64+
- Years since first published
Ensure safe and effective medication use
Highly detailed monographs to support clinical practice
Critical, evidence-based evaluation of relevant clinical data
Compiled without influence from manufacturers, insurers and regulators
Full spectrum of drug therapy including dose, use, pharmacology, safety and pharmacokinetics
Covers licensed and off-licensed usage of medicines
Comprehensive database of prescription and over-the-counter drugs, alternative therapies and supplements
Expertly curated content from AHSP
Latest knowledge updates
Our knowledge products are regularly updated online through MedicinesComplete
22nd May 2023
AHFS Drug Information
This update contains 4 new monographs and 25 revised monographs.
New monographs: Omaveloxolone; Pegcetacoplan (EENT); Sparsentan; Velmanase Alfa-tycv.
Revised monographs: Ambrisentan; Apixaban; Belimumab; Bosentan; Dabigatran; Dupilumab; Emicizumab-kxwh; Epoprostenol; Iloprost; Inebilizumab-cdon; Macitentan; Misoprostol; Naloxone; Nitric Oxide; Omidenepag Isopropyl; Pneumococcal Vaccine; Riociguat; Rivaroxaban; Selexipag; Sildenafil; Smallpox and Mpox Vaccine Live; Tadalafil; Tecovirimat; Treprostinil; Warfarin.
Click to close
11th April 2023
AHFS Drug Information
This update contains 4 new monographs and 18 revised monographs….
11th April 2023
AHFS Drug Information
This update contains 4 new monographs and 18 revised monographs.
New monographs: Daprodustat; Elacestrant; Pirtobrutinib; Sodium Thiosulfate (Protective Agent).
Revised monographs: Apalutamide; Corticosteroids General Statement; Deucravacitinib; Dextromethorphan and Bupropion; Duvelisib; Fingolimod; Interferon Beta; Molnupiravir; Niraparib; Nirmatrelvir and Ritonavir; Roflumilast (Topical); Satralizumab-mwge; Selinexor; Sodium Thiosulfate (Antidote); Terlipressin; Tocilizumab; Vedolizumab; Vosoritide.
Click to close
14th March 2023
AHFS Drug Information
This update contains 9 new monographs, 13 revised monographs, 61…
14th March 2023
AHFS Drug Information
| This update contains 9 new monographs, 13 revised monographs, 61 discontinued monographs and 2 new MedWatch alerts.
New monographs: Adagrasib; Anacaulase (Topical); Fecal microbiota, live; Futibatinib; Lecanemab; Lenacapavir Sodium; Mosunetuzumab-axgb; Sirolimus Protein-bound Particles; Ublituximab. Revised monographs: Amivantamab-vmjw; Evolocumab; Idelalisib; Ketamine; Levoketoconazole; Lumacaftor and Ivacaftor; Lumateperone; Mifepristone; Pneumococcal Vaccine; Rolapitant; Tezacaftor and Ivacaftor; Trametinib Dimethyl Sulfoxide; Vutrisiran. Discontinued monographs: Abametapir; Acrivastine; Alefacept; Altretamine; Amifampridine; Aminohippurate; Aurothioglucose/Gold Sodium Thiomalate; Belantamab Mafodotin-blmf; Benzyl Alcohol; Benzyl Benzoate; Butabarbital; Cefditoren; Ceftibuten; Cellulose Sodium Phosphate; Collagenase Clostridium Histolyticum-aaes; Denileukin; Desirudin; Doripenem; Emedastine; Eprosartan; Etidronate; Fluoxymesterone; Gallium Nitrate; Guanabenz; Hexachlorophene; Hydrogen Peroxide 40%; Hydroxyethyl Starch 130/0.4; Indacaterol; Ingenol Mebutate; Invert Sugar; Isoxsuprine; Liotrix; Lorcaserin; Lutropin Alfa; Maprotiline; Mechlorethamine; Mequinol/Tretinoin; Metaproterenol; Methyclothiazide; Mipomersen; Monobenzone; Morrhuate Sodium; Nedocromil; Nesiritide; Ofatumumab; Panobinostat; Pemirolast; Propantheline; Rimexolone; Saquinavir; Secobarbital; Sodium Thiosalicylate; Tegaserod; Teniposide; Ticlopidine; TOLAZamide; TOLBUTamide; Tolmetin; Umbralisib; Urea 40-50% Injection; Zoster Vaccine Live. New Medwatch alerts on the following monographs: Blinatumomab; Tixagevimab and Cilgavimab. |
Click to close
14th February 2023
AHFS Drug Information
This update contains 7 new monographs, 18 revised monographs and…
14th February 2023
AHFS Drug Information
This update contains 7 new monographs, 18 revised monographs and 2 new MedWatch alerts.
New monographs: Antihemophilic Factor (recombinant), PEGylated; Cysteamine; Olutasidenib; Teclistamab; Teplizumab-mzwv; Tirzepatide; Varenicline.
Revised monographs: Alirocumab; Antihemophilic Factor (recombinant), PEGylated-aucl; Avacopan; Baricitinib; Bempedoic Acid; Elexacaftor, Tezacaftor, and Ivacaftor; Ibrexafungerp; Lonafarnib; Mobocertinib; Molnupiravir; Ocrelizumab; Palivizumab; Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf; Pimavanserin; Pirfenidone; Teriflunomide; Tixagevimab and Cilgavimab; Voclosporin.
New MedWatch alerts on the following monographs: Bebtelovimab; Denosumab.
Click to close
10th January 2023
AHFS Drug Information
This update contains 12 new monographs, 15 revised monographs and…
10th January 2023
AHFS Drug Information
This update contains 12 new monographs, 15 revised monographs and 1 new MedWatch alert.
New monographs: Chloroprocaine (EENT); Eflapegrastim; Emtricitabine and Tenofovir Alafenamide; Emtricitabine and Tenofovir Disoproxil Fumarate; Mirvetuximab Soravtansine-gynx; Mitapivat; Sodium Phenylbutyrate and Taurursodiol; Sutimlimab; Tapinarof; Tremelimumab; Vonoprazan and Amoxicillin; Vonoprazan, Clarithromycin, and Amoxicillin.
Revised monographs: Abrocitinib (Topical); Asciminib; COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Novavax); COVID-19 Vaccine (Pfizer-BioNTech); Darolutamide; Empagliflozin; Fostemsavir; Imipenem, Cilastatin Sodium, and Relebactam; Ivacaftor; Lasmiditan; Margetuximab; Naltrexone and bupropion; Peginterferon Beta-1a; Ropeginterferon Alfa-2b.
New MedWatch alert on the following monograph: Belantamab Mafodotin-blmf.
Click to close
31st December 2022
AHFS Drug Information
This update contains 4 new monographs and 21 revised monographs….
31st December 2022
AHFS Drug Information
This update contains 4 new monographs and 21 revised monographs.
New monographs: Omidenepag Isopropyl; Sodium Nitrite; Sodium Thiosulfate; Tebentafusp.
Revised monographs: Abiraterone; Brexanolone; Buprenorphine; Capecitabine; Ceritinib; COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Pfizer-BioNTech); Dabrafenib; Dalfampridine; Enasidenib; Influenza Vaccine Live Intranasal; Influenza Vaccine Recombinant; Influenza Virus Vaccine Inactivated; Lapatinib; Lusutrombopag; Mifepristone; Misoprostol; Oxaliplatin; Tezepelumab-ekko; Vancomycin; Venetoclax.
Click to close
Request access today
Access AHFS Drug Information through MedicinesComplete today.
Contact us now for pricing and access information.
Related knowledge products
Related publications
-
PRE-ORDERPharmacy Management of Long-term Medical Conditions
Focuses on long-term medical conditions (LTMCs) including an overview, diagnosis, and management/tre…
Info -
FEATUREDDisease Management Third Edition
A comprehensive discussion on the management of diseases which are commonly encountered by pharmacis…
Info -
BEST SELLERRules and Guidance for Pharmaceutical Manufacturers and Distributions (The MHRA Orange Guide) 2022
The reference for manufacturers and distributors of medicines in Europe and the UK
Info
See all our printed publications in the Shop.
Access the essential knowledge you need today
Opens in a new window
Environment: dev